Skip to content
JNJJohnson & Johnson

JNJ Earnings

Johnson & Johnson next reports earnings on October 13, 2026. Track record: 3/4 beats.

Earnings Reported

October 13, 2026

Current Price

$273.20

EPS Estimate

Earnings Per Share

$2.92

+18.5% YoY

Trailing EPS

Last 12 months earnings

$6.59

Beat Rate

3/4

75%

Forward P/E

Price-to-Earnings ratio

23.5

Margin: 16.2%

Analyst Rating

Buy

22 analysts

Analyst Sentiment

Buy22 analysts
Target: $279.41+2.3%Full analysis →

Earnings History

3/4 Beats
QuarterEPS Est.EPS ActualSurpriseResult
2026-09-30$2.52$2.59+2.7%Beat
2026-06-30$2.85$2.90+1.6%Beat
2026-03-31$2.68$2.70+0.9%Beat
2025-12-31$2.46$2.46-0.1%Miss

Growth Estimates

PeriodEPS Est.Growth
Current Qtr(0q)$2.92+18.5%
Next Qtr(+1q)$2.68-0.9%
Current Year(0y)$11.12+3.1%
Next Year(+1y)$11.62+4.5%

Next Quarter Estimates

EPS Estimate

Earnings Per Share

$2.92

Revenue Estimate

$26.4B

Annual EPS Est.

$11.12

+3.1% YoY

JNJ Earnings FAQ

When is JNJ's next earnings date?

Johnson & Johnson (JNJ) is expected to report earnings on October 13, 2026. The consensus EPS estimate is $2.92.

Does JNJ usually beat earnings estimates?

Johnson & Johnson has beaten Wall Street EPS estimates in 3 of the last 4 quarters (75% beat rate).

What is JNJ's trailing EPS?

Johnson & Johnson's trailing twelve-month EPS is $6.59. This is calculated from the last four quarters of reported earnings.

What do analysts think about JNJ?

22 Wall Street analysts cover Johnson & Johnson. The consensus rating is "Buy" with an average price target of $279.41, implying 2.3% upside from the current price.